Form 4: Abbott CFO Sells Shares for Tax Obligations

Abbott Laboratories' EVP and CFO, Philip P. Boudreau, disposed of 7,441 common shares to cover tax withholding obligations.

Summary

• Philip P. Boudreau, Executive Vice President and Chief Financial Officer of Abbott Laboratories (ABT), reported a transaction.
• On February 27, 2026, Boudreau disposed of 7,441 common shares without par value.
• The shares were disposed of at a price of $116.26 per share.
• This transaction was coded 'F', indicating a disposition to the issuer to satisfy tax withholding obligations.
• Following this transaction, Boudreau directly beneficially owns 71,172 common shares.
• Additionally, Boudreau indirectly beneficially owns 366 common shares through the Abbott Laboratories Stock Retirement Trust.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The disposition of shares is a routine transaction for tax withholding purposes and does not indicate a change in the company's operational performance or outlook.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Abbott Laboratories' future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those marked with transaction code 'F' for tax withholding, are common and generally do not reflect a change in management's confidence in the company's prospects or broader industry trends. Such transactions are typically pre-scheduled and routine.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, tax-related transaction by an executive.
• No direct impact on employees, customers, suppliers, or creditors is indicated by this filing.

Key Dates

Keywords

Abbott Laboratories, ABT, Form 4, Insider Trading, Share Sale, Philip P. Boudreau, CFO, Tax Withholding, Equity Transaction